Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Status:
Active, not recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, long-term, extension, phase 2 study to evaluate the safety
and efficacy of long-term treatment with DS-5141b in patients with DMD who have completed
DS5141-A-J101.